We, then examined the expression of mIR-25 in SVECs from patients with advanced atherosclerosis and type 2 diabetes, showing increased mIR-25 consistent with the reduced Nox4 seen in ECs from these patients. This evidence concerns the gene NOX4 and atherosclerosis.